RxDoctor Payments Data

Brandon Bushnell, MD

Orthopaedic Surgery · Rome, GANPI 1770704629

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $102,067 of the $160,385 with a category attached, or 63.6%. Smith+Nephew accounts for 99.0% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $40,819 and has fallen 52.4% since, to $19,445 in 2025. Among orthopaedic surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,385in general payments, 2019–2025

Across 235 payments — averaging $682.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$159K
  • Johnson & Johnson$420
  • Stryker$174
  • Anika Therapeutics, Inc.$166
  • Pacira Therapeutics, Inc.$124
  • Dynasplint Systems Inc.$122
  • plus $564 from 11 others
$209,713in research payments, 2019–2025

Across 87 payments — averaging $2410.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$210K

What the payments were for

  • Consulting fees$29,45518%
  • Speaking & faculty fees$102,06764%
  • Travel & lodging$23,55415%
  • Food & beverage$5,3093%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$160,385 in reported general payments places this provider in the 95th percentile of 654 orthopaedic surgery providers in Georgia.

See all orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$211,182
Medicare patients
438
Services billed
4,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen118$1,135
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$452
Celecoxib23$322
Cephalexin56$282
Tramadol Hcl30$80
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$62
Amoxicillin14$16

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rome

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →